Navigation Links
Specialty Pharmaceutical Distributor BDI Pharma Posts Record Sales Revenues for Third Quarter 2013
Date:10/31/2013

COLUMBIA, S.C., Oct. 31, 2013 /PRNewswire/ -- BDI Pharma, Inc. today announced record sales revenues for Q3 2013, representing a 39% increase compared to the same time period in 2012. This continues the upward trend from the second quarter driving overall growth for the year to over 38%.

(Photo:  http://photos.prnewswire.com/prnh/20131031/PH07564-a)
(Logo:  http://photos.prnewswire.com/prnh/20131031/PH07564LOGO-b)

"While we continue to evolve the concept of specialty distribution, it is important that we maintain a strong focus on our core competencies," states Richard J. Gaton, Co-President of BDI Pharma. "One of our top priorities over the past six months has been to increase our level of sophistication as a company. From this, we have seen an immediate impact on our revenues, having the most successful financial quarter in BDI Pharma's nearly two decades of existence."

BDI is confident that their focus on core competency enhancements and strategic expansion into alternative distribution will continue this upward trend. "It is encouraging to experience this type of success while simultaneously solving supply chain issues for our manufacturing partners," adds Rick Schindewolf, CFO, BDI Pharma.

About BDI Pharma, Inc.

BDI Pharma has continuously refined the concept of niche distribution, providing solutions beyond the traditional wholesaler model since 1995. We operate as an extension of our partners' sales force, create demand, and move market share with each transaction. In this regard, we maintain a highly selective process when entering into a strategic partnership. Our approach of serving the manufacturers as well as the customers over nearly two decades has proven successful in varied market conditions. This is further supplemented through innovative supply solutions, extensive product knowledge, 24/7 emergency availability and urgent need delivery. An open-access resource for reference material, educational literature, market data and online ordering, BDI Pharma's home web page www.bdipharma.com (also www.ivig.com) has become an industry-renowned point of reference.  Proprietary programs covering comprehensive reimbursement services - www.bdiaccess.com and 855-BDI-CARE; and product consignment - www.bdivantageplus.com; are just a few of the solutions tailored to the needs of the healthcare community.

BDI Pharma's product portfolio includes IVIG, branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, coagulation factors, high-titer or "hyper" immune globulins, and other specialty injectables. BDI Pharma is recognized as an "ADR," or Authorized Distributor of Record, for all of the manufacturers it represents.

Contact: Brad Davis
800-948-9834
Email

Read more news from BDI Pharma.


'/>"/>
SOURCE BDI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aptel Research Launches Unique Patient-centric Syndicated Report Series That Analyze the Patient Journey for Chronic Diseases in Specialty Markets
2. UHC to Launch New Specialty Pharmacy Program for Better Continuity of Patient Care, Improved Access to Specialty Pharmaceuticals
3. TRICAST Hosts Annual Round Table Assessment of Mid-Market Pharmacy Benefit Managers, Specialty Providers
4. Endo to Acquire Specialty Generics Company Boca Pharmacal
5. Wolters Kluwer Health Launches Nursing Drug Handbook Specialty Apps
6. Cardinal Health Makes It Easier For Community Pharmacies To Help Patients Access, Improve Compliance With Specialty Medications
7. Amerigen Pharmaceuticals Limited today announced it had entered into a collaboration agreement with Forest Laboratories Inc. regarding the development of a number of specialty generic products.
8. Oncology remains most restrictive specialty for second year
9. National Association of Specialty Pharmacy (NASP) Partners with the Patient Access Network (PAN) Foundation to Host Charity Golf Outing at Upcoming Meeting
10. Roger Graham Named President of Mylan Specialty
11. Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... 12, 2017   EcoVadis , the leading platform for environmental, social ... annual edition of its Global CSR Risk and Performance Index. The report ... based on Scorecard Ratings that analyzed nearly 800,000 data points across the ... ... ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
(Date:10/12/2017)... BALTIMORE (PRWEB) , ... October 12, 2017 , ... ... average of $3,296 in property taxes a year. In some states—like New York, ... higher. , By contrast, many overseas retirement havens have extremely low property-tax rates, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
(Date:10/12/2017)... ... October 12, 2017 , ... Nvision Biomedical Technologies ... with the addition of industry sales leader, Thomas (Tom) Slott, as Senior Vice ... distribution and sales network, direct the efforts of the surgical sales teams, manage ...
Breaking Medicine News(10 mins):